These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 17914643
1. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors. Liu A, Guang H, Zhu L, Du G, Lee SM, Wang Y. Sci China C Life Sci; 2007 Dec; 50(6):726-30. PubMed ID: 17914643 [Abstract] [Full Text] [Related]
2. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. Akula N, Lecanu L, Greeson J, Papadopoulos V. Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6277-80. PubMed ID: 17049234 [Abstract] [Full Text] [Related]
3. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis. Roy KK, Dixit A, Saxena AK. J Mol Graph Model; 2008 Sep 15; 27(2):197-208. PubMed ID: 18515163 [Abstract] [Full Text] [Related]
4. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. Gurung AB, Aguan K, Mitra S, Bhattacharjee A. J Biomol Struct Dyn; 2017 Jun 15; 35(8):1729-1742. PubMed ID: 27410776 [Abstract] [Full Text] [Related]
5. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease. Zhou A, Hu J, Wang L, Zhong G, Pan J, Wu Z, Hui A. J Mol Model; 2015 Oct 15; 21(10):277. PubMed ID: 26438408 [Abstract] [Full Text] [Related]
6. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors. Chaudhaery SS, Roy KK, Saxena AK. J Chem Inf Model; 2009 Jun 15; 49(6):1590-601. PubMed ID: 19441865 [Abstract] [Full Text] [Related]
7. 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method. Li YP, Weng X, Ning FX, Ou JB, Hou JQ, Luo HB, Li D, Huang ZS, Huang SL, Gu LQ. J Mol Graph Model; 2013 Apr 15; 41():61-7. PubMed ID: 23500628 [Abstract] [Full Text] [Related]
9. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors. Shen LL, Liu GX, Tang Y. Acta Pharmacol Sin; 2007 Dec 15; 28(12):2053-63. PubMed ID: 18031622 [Abstract] [Full Text] [Related]
10. 2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors. Nazari M, Tabatabai SA, Rezaee E. Curr Comput Aided Drug Des; 2018 Dec 15; 14(4):391-397. PubMed ID: 30047333 [Abstract] [Full Text] [Related]
11. 2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors. Niu B, Zhao M, Su Q, Zhang M, Lv W, Chen Q, Chen F, Chu D, Du D, Zhang Y. Mol Divers; 2017 May 15; 21(2):413-426. PubMed ID: 28275924 [Abstract] [Full Text] [Related]
12. Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. Martis EA, Chandarana RC, Shaikh MS, Ambre PK, D'Souza JS, Iyer KR, Coutinho EC, Nandan SR, Pissurlenkar RR. J Biomol Struct Dyn; 2015 May 15; 33(5):1107-25. PubMed ID: 24905476 [Abstract] [Full Text] [Related]
13. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives. Zhang S, Hou B, Yang H, Zuo Z. Arch Pharm Res; 2016 May 15; 39(5):591-602. PubMed ID: 26832327 [Abstract] [Full Text] [Related]
14. Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE). Araújo JQ, de Brito MA, Hoelz LV, de Alencastro RB, Castro HC, Rodrigues CR, Albuquerque MG. Eur J Med Chem; 2011 Jan 15; 46(1):39-51. PubMed ID: 21074294 [Abstract] [Full Text] [Related]
15. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors. Ul-Haq Z, Mahmood U, Jehangir B. Chem Biol Drug Des; 2009 Dec 15; 74(6):571-81. PubMed ID: 19843075 [Abstract] [Full Text] [Related]
16. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. Gharaghani S, Khayamian T, Ebrahimi M. SAR QSAR Environ Res; 2013 Dec 15; 24(9):773-94. PubMed ID: 23863115 [Abstract] [Full Text] [Related]
17. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors. Daoud I, Melkemi N, Salah T, Ghalem S. Comput Biol Chem; 2018 Jun 15; 74():304-326. PubMed ID: 29747032 [Abstract] [Full Text] [Related]
18. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors. Jiang YR, Yang YY, Chen YL, Liang ZJ. Curr Comput Aided Drug Des; 2013 Sep 15; 9(3):385-95. PubMed ID: 24010934 [Abstract] [Full Text] [Related]
19. 3D-QSAR studies on natural acetylcholinesterase inhibitors of Sarcococca saligna by comparative molecular field analysis (CoMFA). Zaheer-ul-Haq, Wellenzohn B, Tonmunphean S, Khalid A, Choudhary MI, Rode BM. Bioorg Med Chem Lett; 2003 Dec 15; 13(24):4375-80. PubMed ID: 14643329 [Abstract] [Full Text] [Related]
20. Validation of protein-based alignment in 3D quantitative structure-activity relationships with CoMFA models. Golbraikh A, Bernard P, Chrétien JR. Eur J Med Chem; 2000 Jan 15; 35(1):123-36. PubMed ID: 10733609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]